in this study, we sought to investigate the impact of photobiomodulation and adipose-derived stem cells (ADS), alone and in combination, on the maturation step of wound healing in an ischemic infected delayed healing wound model in rats with type 2 diabetes mellitus (DM2). We randomly divided 24 adult male rats into 4 groups (n = 6 per group). DM2 plus an ischemic delayed healing wound were induced in all rats. the wounds were infected with methicillin-resistant Staphylococcus aureus. Group 1 was the control (placebo) group. Group 2 received only photobiomodulation (890 nm, 80 Hz, 0.324 J/cm 2 , and 0.001 W/cm 2 ). Group 3 received only the allograft ADS. Group 4 received allograft ADS followed by photobiomodulation. On days 0, 4, 8, 12, and 16, we performed microbiological examination (colony forming units, [CFU]), wound area measurement, wound closure rate, wound strength, and histological and stereological examinations. The results indicated that at day 16, there was significantly decreased cfU (Analysis of variance, p = 0.001) in the photobiomodulation + ADS (0.0 ± 0.0), ADS (1350 ± 212), and photobiomodulation (0.0 ± 0.0) groups compared with the control group (27250 ± 1284). There was significantly decreased wound area (Analysis of variance, p = 0.000) in the photobiomodulation + ADS (7.4 ± 1.4 mm 2 ), ADS (11 ± 2.2 mm 2 ), and photobiomodulation (11.4 ± 1.4 mm 2 ) groups compared with the control group (25.2 ± 1.7). There was a significantly increased tensiometeric property (stress maximal load, Analysis of variance, p = 0.000) in the photobiomodulation + ADS (0.99 ± 0.06 N/ cm 2 ), ADS (0.51 ± 0.12 N/cm 2 ), and photobiomodulation (0.35 ± 0.15 N/cm 2 ) groups compared with the control group (0.18 ± 0.04). There was a significantly modulated inflammatory response in (Analysis of variance, p = 0.049) in the photobiomodulation + ADS (337 ± 96), ADS (1175 ± 640), and photobiomodulation (69 ± 54) treatments compared to control group (7321 ± 4099). photobiomodulation + ADS gave significantly better improvements in CFU, wound area, and wound strength compared to photobiomodulation or ADS alone. Photobiomodulation, ADS, and their combination significantly hastened healing in ischemic methicillin-resistant Staphylococcus aureus infected delayed healing wounds in rats with DM2. Combined application of photobiomodulation plus ADS demonstrated an additive effect.
www.nature.com/scientificreports www.nature.com/scientificreports/ Microbial findings. Day 8. All p-values were attributed to the least significant difference (LSD) test.
Treatment with photobiomodulation + ADS, photobiomodulation, and ADS significantly decreased CFU of in the wounds compared with the control group (all, p = 0.000). In addition, photobiomodulation + ADS treatment was statistically better than treatment with only photobiomodulation (p = 0.012) and ADS alone (p = 0.002). Treatment with only photobiomodulation significantly decreased CFU in comparison with ADS treatment (p = 0.002, Fig. 4 ).
Day 16. There were no detectable CFU in the wounds treated with the photobiomodulation + ADS and only photobiomodulation. There were significant decreases in CFU in the photobiomodulation + ADS, photobiomodulation, and ADS groups compared with the control group (all, p = 0.000). Photobiomodulation + ADS and treatment with only photobiomodulation were significantly better than treatment with only ADS (both, p = 0.046, Fig. 4 ).
Wound area measurement. Day 4 . Panel A of Fig. 5 shows the measurements of the wound areas of the study groups. Photobiomodulation + ADS, photobiomodulation, and ADS treatments significantly decreased the wound area compared with the control group (p = 0.000, p = 0.003, p = 0.028). At the same time, photobiomodulation + ADS treatment significantly decreased wound area compared with only ADS treatment (p = 0.014; Fig. 5 , panel A). Immunophenotypes of these ADS cells showed that they expressed some clusters of differentiation (CD) 45 (B) and CD11b (C), and completely expressed CD 44H (D) and CD 105 (E). Table 1 . Mean ± standard deviation (SD) of body weights and blood sugar levels of the four groups compared by paired student's t-test. PBM, photobiomodulation; ADS, adipose-derived stem cells; STZ, Streptozotocin. Initial (primary) weight was measured at the beginning of the fructose feeding. The secondary weight was obtained at the end of the fructose feeding. **p < 0.01; ***p < 0.001. Day 8. Photobiomodulation + ADS, photobiomodulation, and ADS treatments significantly decreased the wound area compared to the control group (all, p = 0.000). Simultaneously, photobiomodulation + ADS treatment significantly decreased the wound area compared to only the photobiomodulation (p = 0.006) and only ADS treatments (p = 0.019; Fig. 5 , panel A).
GROUPS
Day 12. Photobiomodulation + ADS, photobiomodulation, and ADS treatments significantly decreased the wound areas compared to the control group (all p = 0.000). Both the photobiomodulation + ADS and ADS alone treatments significantly decreased wound area compared with photobiomodulation alone treatment (both p = 0.000). At the same time, photobiomodulation + ADS treatment significantly decreased the wound area compared with ADS treatment (p = 0.018). Treatment with only ADS significantly decreased the wound area compared with the photobiomodulation alone treatment (p = 0.000; Fig. 5 , panel A).
Day 16. Photobiomodulation + ADS, photobiomodulation, and ADS treatments significantly decreased the wound area compared with the control group (all p = 0.000). Simultaneously, photobiomodulation + ADS treatment significantly decreased wound area compared to the photobiomodulation alone (p = 0.001) and ADS alone (p = 0.003) treatments ( Fig. 5 Findings of tensiometerical properties, bending stiffness. Photobiomodulation + ADS, ADS, and photobiomodulation treatments showed significantly increased bending stiffness compared to the control group (p = 0.000, p = 0.000, p = 0.001). Concurrently, photobiomodulation + ADS treatment significantly increased bending stiffness to a greater extent than treatments with photobiomodulation alone and ADS alone (both p = 0.000). ADS treatment significantly increased bending stiffness in comparison with photobiomodulation treatment (p = 0.000; Fig. 6 , panel A). www.nature.com/scientificreports www.nature.com/scientificreports/ Maximum force. Photobiomodulation + ADS, ADS, and photobiomodulation treatments significantly increased the maximum force compared to the control group (p = 0.000, p = 0.000, p = 0.034). Concurrently, photobiomodulation + ADS treatment significantly increased maximum force to a greater extent than the photobiomodulation alone and ADS alone treatments (both p = 0.000). ADS treatment significantly increased maximum force in comparison with the photobiomodulation treatment (p = 0.037; Fig. 6 , panel B).
Stress maximum load.
There was significantly increased stress maximum load in the photobiomodulation + ADS (p = 0.000), ADS (p = 0.000), and photobiomodulation (p = 0.030) treatments compared with the control group. Concurrent administration of photobiomodulation + ADS significantly increased stress maximum load to a greater extent than photobiomodulation alone and ADS alone (both p = 0.000). ADS treatment significantly increased stress maximum load in comparison with photobiomodulation treatment (p = 0.032; Fig. 6 , panel C). www.nature.com/scientificreports www.nature.com/scientificreports/ energy absorption. Photobiomodulation + ADS, ADS, and photobiomodulation significantly increased energy absorption compared with the control group (all p = 0.000). Photobiomodulation + ADS treatment significantly increased energy absorption to a greater extent than treatment with only photobiomodulation (p = 0.000) and only ADS (p = 0.042). ADS treatment significantly increased energy absorption in comparison with photobiomodulation treatment (p = 0.000; Fig. 6 , panel D).
Stereologic findings.
In terms of inflammatory cells, there were significantly better results (lower values) in the photobiomodulation + ADS, photobiomodulation, and ADS groups compared with the control group. There were no significant differences in fibroblast numbers and vascular length among the studied groups ( Fig. 7) . We observed significantly less neutrophil counts in the photobiomodulation (p = 0.006), photobiomodulation + ADS (p = 0.014), and ADS (p = 0.025) groups compared with the control group ( Fig. 7 , panel A). We observed a significant decrease in macrophage counts in the photobiomodulation (p = 0.038) and photobiomodulation + ADS (p = 0.041) groups compared with the control group ( Fig. 7, panel B ). Treatment with photobiomodulation, photobiomodulation + ADS, and ADS significantly decreased inflammatory cells (neutrophils plus macrophages) compared with the control group (p = 0.021, p = 0.026, p = 0.039; Fig. 7 , panel C). Figure 8 shows the histological micrographs of the four study groups, which were stained with Hematoxylin and Eosin staining method.
Results of mallory's trichrome staining.
In control group collagen fibers orientation were mixed, while in treatment groups were mostly horizontal ( Fig. 8 ). In control group pattern of collagen fibers were mostly reticular and thin, whereas in treatment groups they were mostly fascicular and they seem thicker than collagen fibers of the control group ( Fig. 8 ).
Discussion
In this study, we investigated the impact of individual or combined administration of photobiomodulation and allograft ADS on the maturation step of wound healing in an ischemic delayed healing infected wound model in DM2 rats. The results from this study indicated that all three treatment regimens significantly decreased CFU and the wound area, and significantly increased wound strength. Regarding CFU and wound area, co-treatment with photobiomodulation and ADS was significantly more effective than individual photobiomodulation or ADS treatments. Microbiological examination showed that photobiomodulation treatment was significantly better than ADS treatment. However, treatment with ADS was significantly better than photobiomodulation for the wound area measurement, and wound strength tests. Our assessment of inflammatory cells showed significantly better results (lower values) in the photobiomodulation + ADS, photobiomodulation, and ADS groups compared with the control group. There were no significant differences in fibroblast numbers and vascular length among the four study groups (Fig. 7) . In current study the results of fibroblast count and Mallory's trichrome staining were in the line of wound strength examination.
Complications with DFUs include an aberrant wound micro milieu, excessive inflammation, and angiogenesis maladies 31 . DFU occurs in the setting of ischemia, infection, neuropathy, and metabolic disorders. This results in poor wound healing and poor treatment options. In a review article, Lopes et al. have stated that existing proof points toward stem cell therapy as a persuasive cure for DFU 32 . Clinical and preclinical research studies have not provided any consensus regarding the optimum category of stem cell that should be used and there is no well-known optimal route or regimen for delivery of the stem cells. Differences within preclinical study designs suggest the need for an agreement regarding an optimum animal model that suggests translation to human studies. Variations in the stem cell category and source, route, and regimen for administration also confound easy interpretation and generalization of the results 32 . According to Lopes et al., there is an urgent need for additional experimentation to find a good animal model and persuasive regimens of stem cell therapy for treating severe cases of DFU. In the current study, for the first time, we have evaluated the combined effect of ADS plus photobiomodulation on a delayed healing wound model in rats. ADS are considered beneficial for use in regenerative medicine treatment regimens. Their chief benefit compared to mesenchymal stem cells extracted from other origins, www.nature.com/scientificreports www.nature.com/scientificreports/ such as the bone marrow, is their simple and reproducible extraction by relatively non-invasive methods. ADS also do not undergo immunological reactions and do not require matching of major histocompatibility antigen subtype for allogeneic engraftment 33, 34 . ADS can differentiate into vascular endothelial cells 33 and their engraftment stimulates new blood vessel formation and increases blood flow to the ischemic tissue in animal models 15, 35 . It has been reported that growth factors released by ADS stimulate arteriogenesis in ischemic tissue by paracrine signaling 15 . A previous investigation from one of the authors of the current study has demonstrated that ADS immunomodulatory feature, brought it as an appropriate approach in treatment of some inflammatory diseases beyond the diabetic condition 36 . Recent investigations have shown a significant decrease in viable mesenchymal stem cell counts in animal models of skin injury and skull defects within the first 14 days of engraftment 37, 38 .
One study demonstrated that some of the implanted ADS expressed endothelial markers in ischemic organs, but the hypoxic milieu of the ischemic organ by inducing cell death reduced the vascular incorporation rate of the ADS 39 . To improve this treatment, it is essential to improve stem cell function to enable their survival within ischemic tissue and have the capability to differentiate into vascular cells 40 . Approaches for promoting and increasing viability and engraftment of stem cells within ischemic tissue have been proposed and include transplantation mixed with a cytokine release system 40 , genetic modification of stem cells 41 , and the use of cell-implantation scaffolds 42 . While transplantation of stem cells plus the cytokine release system enhances stem cell viability, this approach presents difficulties for extensive medical use. A reproducible and organized delivery system should be established to extend the in vivo action of cytokines and prevent probable side effects 40 .
Guo and DiPietro, in their review article, emphasized the importance of wound strength in different medical situations 43 . Our study showed that treatment of wounds with ADS significantly increased wound strength compared to the control and photobiomodulation groups. This result showed the importance of ADS in treating nonhealing wounds such as diabetic wounds. However, we observed that combined administration of ADS and photobiomodulation demonstrated an additive effect.
Photobiomodulation has been extensively applied to enhance local circulation and improve injury repair by triggering new blood vessel formation in some non-diabetic animal models of ischemic tissues. Cury et al. have examined the impact of photobiomodulation (660 nm and 780 nm, 30 and 40 J/cm 2 ) on three key mediators activated during new blood vessel formation in experimental models of random skin flaps. Tissues were collected from random skin flaps and they assessed the numbers of vessels, angiogenesis markers, and a tissue maturation marker. Cury et al. reported that photobiomodulation increased angiogenesis markers, and decreased tissue maturation markers. These phenomena varied according to energy density and depended on the wavelength 44 . In another study, Park et al. examined the effect of photobiomodulation on transplanted ADS in a mouse model of ischemic random skin flap and reported more cytokines released in the ADS + photobiomodulation group compared with the ADS group. ADS treatment improved tissue repair by endothelial cell differentiation and release of angiogenic growth factors. The ADS + photobiomodulation group showed better treatment efficiency in comparison with the ADS group, which was attributed to improved random skin flap viability, along with increased paracrine release. The enhanced paracrine release of angiogenic growth factors might be attributed to improve ADS viability by prevention of apoptosis 45 . Takhtfooladi et al. tested the impact of photobiomodulation (Al-Ga-In-P laser; 670 nm; 4 J/cm²; 40 mW/cm²) on ischemia-reperfusion of a skeletal muscle injury in rats 46 . They reported that photobiomodulation protected against the initial inflammatory response, prevented muscle atrophy and necrosis, and stimulated new blood vessel formation after the ischemia-reperfusion injury.
The effects of photobiomodulation plus conditioned medium of cultured human BMMSCs on infected wounds of diabetic rats have been studied by the Bayat group. In these animal studies, the researchers administered Streptozotocin to create a rat model of DM1. In the first study, Kouhkheil et al. reported the positive impacts of single or dual administration of photobiomodulation (890 nm, 80 Hz, 0.2 J/cm 2 ) and/or hBMMSC-conditioned medium (4 injections) on CFU and wound strength of a MRSA infected wound model in DM1 rats 28 . In the second study, Fridoni et al. reported the beneficial effect of single or dual administration of photobiomodulation (890 nm, 80 Hz, 0.2 J/cm 2 ) and/or conditioned medium from hBMMSC (four injections) on stereological parameters in an MRSA infected wound model in DM1 rats 29 .
To our knowledge, the effect of dual treatment with photobiomodulation plus ADS on the repair of infected wounds in DM2 animals (or humans) has not been reported. The present study aimed to assess the impacts of photobiomodulation plus ADS on microbial flora, wound area, wound strength, and histological and stereological parameters in DM2 rats. We found that the single administration of photobiomodulation or ADS, and the combined administration of photobiomodulation plus ADS significantly hastened wound repair in MRSA infected wounds of DM2 rats. Additionally, the combination of photobiomodulation and ADS provided an additive effect, which probably resulted from the enhanced survival of ADS due to the inhibitory effect of photobiomodulation on apoptosis and robust paracrine signaling of ADS 45, 47 .
Lipoveski et al. conducted an in vitro study on the antibacterial property of blue light (415 nm, 100 mW, and 30, 60, 120 J/cm 2 ), which showed the inhibitory effect of photobiomodulation on Staphylococcus aureus by reactive oxygen species induction 11 . It is possible that bactericidal effect of photobiomodulation treatment in our study could be attributed to the induction of reactive oxygen species. However, we used near-infrared light rather than blue light.
Different wavelengths of photobiomodulation have been tested on fibroblast survival and proliferation in a high glucose culture system. Cells irradiated in the red range of light (632.8 nm) showed a higher degree of cell viability and proliferation compared to cells subjected to photobiomodulation in the near-infrared range (830 nm). From these results, it might be concluded that diabetic cells could benefit from irradiation in the red range rather than the near-infrared range in terms of wound healing 48 . However, since near-infrared laser has a deeper penetration rate than red laser 49 , deeper wounds in vivo might require the use of near-infrared and infrared 48 lasers such as the 890 nm laser used in the present study.
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(2020) 10:1206 | https://doi.org/10.1038/s41598-020-58099-z www.nature.com/scientificreports www.nature.com/scientificreports/ In the current study, stereological analysis supported our hypothesis that the treatments, particularly photobiomodulation plus ADS modulated the inflammatory response, simultaneously increased wound strength, and significantly decreased the wound area and CFU. Bayat and Chien have reported the positive effects of combined application of ADS and photobiomodulation in some ischemic tissues. They stressed that these results might support new healing attitudes for a cure and resolution of delayed healing of DFU in patients. They hypothesized that an ideal combination of mesenchymal stem cells and photobiomodulation would accelerate the wound healing process. This approach could modulate the immune system in diabetic patients who have delayed healing and infected DFU. The combined application of ADS and photobiomodulation would be significant, not only for advancing the development of a new treatment for delayed healing and infected DFUs in diabetic patients, but it would also provide new findings about modulating the inflammatory response in DFUs 50 .
However, more specific studies are necessary to understand the exact role of inflammation in the healing process. In order to investigate the effects of photobiomodulation and ADS on the promotion of M2 polarization in vivo, CD206/CD68 immunofluorescence staining should be performed on wound tissue sections and oxidative stress levels should be evaluated.
According to the literature, the bipedicle skin flap is an established model of ischemia [51] [52] [53] . In the current experiment, for the first time, we initially created a bipedicle skin flap on the back of each rat followed by an excisional wound in the flap. Finally, we inserted a silicone ring around the wound (Fig. 9 ). This approach could reduce the wound closure induced by the skin muscle 54 and would allow the wound to predominantly rebuild by re-epithelialization and granulation tissue formation, which resemble the wound healing process in humans. Our pilot study has shown that this wound (ring + ischemic) model heals slower compared to a non-ischemic wound without any ring in healthy animals. Ischemia, neuropathy, and infection are three pathological components that lead to diabetic foot complications. They frequently occur together as an etiologic triad 55 . In the current experiment, we generated an ischemic delayed healing skin injury that was infected with MRSA to simulate the worst cases of DFU in an animal model.
conclusion
The application of photobiomodulation and ADS alone or in combination significantly hastened wound healing in an ischemic delayed healing MRSA infected wound model in rats with DM2. The combined use of photobiomodulation and ADS demonstrated an additive effect. We suggest that photobiomodulation combined with ADS could be investigated in human translational studies to reduce inflammation and infection, and promote healing. Induction of type 2 diabetes mellitus. Initially, the animals were fed with 10% fructose (Biobasic, Canada) in drinking water (instead of pure water) plus standard chow pellets for rats for 14 days. Next, each animal received an injection of intraperitoneal injection of Streptozotocin 56 . After seven days, the rats' blood sugar levels were measured. Animals with blood sugar levels higher than 250 mg/dl were considered to have DM2 26 .
Clinical examinations. Body weights and blood sugar levels of rats were monitored throughout the experiment.
Surgery. The rats were anesthetized by intramuscular (i.m.) injections of ketamine (50 mg/kg) and xylazine (5 mg/kg). The rats received ceftriaxone (50 mg/kg, i.m.) before the surgery, and again at 24 h and 48 h after surgery. A dorsal, bipedicle skin flap (10 × 3.5 cm) was induced deep into the skin and underlying skin muscle. One, 12 mm full thickness excisional round wound that included the skin muscle was produced in the midpoint region of the flap using a biopsy punch. A donut-shaped silicone skin holder was fixed around each skin defect with a 04 silk suture ( Fig. 9 ). Prior to surgery, all rats received 20 mg/kg ibuprofen every 8-12 h, which was continued until five days after surgery.
Inoculation of MRSA into the wounds and microbiological examination. We used the MRSA strain ATCC 25923. The procedure was fully described in our previous study 28, 29 . A single colony of MRSA was inoculated into liquid medium to a final concentration of 2 × 10 8 cells/mL. A 100 μl aliquot of the suspension that contained 2 × 10 7 MRSA cells was topically inoculated onto each wound immediately after surgery. We obtained microbiological samples for routine microbiological analysis from the wounds on days 8 and 16. The numbers of bacteria per sample were counted as CFUs.
photobiomodulation. The wounds of rats in groups 3 and 4 were subjected to photobiomodulation (Mustang 2000, LO7 pen, Technica Co., Russia, Table 2 ) while the rats were sedated ( Fig. 9) 26 . In the present probe, the region of the target tissue (including the wound and surrounding skin, Fig. 9 ) was larger than the pen's spot size. Therefore, we applied sequential treatments to ensure that each unit area received a similar laser energy density. Photobiomodulation was done over nine distinct regions, including the wound area and surrounding normal skin, with the laser pen held perpendicular to the target tissue and at a distance of less than 5 mm per area. The probe was covered with a very thin sterile disposal cover to ensure that infection was not transmitted to the other animals as well as transmission of the laser without any disturbance. During laser radiation, the irradiated animals were sedated by half doses of the anesthetizing drugs. Photobiomodulation was continued once per day, for six days a week until day 16.
Preparation of allograft ADS. The ADS were obtained from adipose tissue within the abdominal region of healthy adult rats as described previously 57, 58 . About 3 cm 3 of adipose tissue was manually minced and subjected to digestion with 0.1% collagenase type I solution for 25 min at 37 °C, and then centrifuged. The cell pellets were suspended in Dulbecco's Modified Eagle's Medium (DMEM) plus 20% fetal bovine serum and then seeded into T-75 flasks that contained DMEM, 20% fetal bovine serum, 100 U/ml penicillin, and 100 µg/ml streptomycin. The ADS were characterized for mesenchymal stem cell markers by flow cytometry, as reported previously 57, 58 .
ADS transplantation.
At 24 h after surgery, we suspended 1 × 10 6 passage-4 ADS 47 in 300 µl phosphate-buffered saline 45 . The rats received intradermal injections of this solution via an insulin syringe into eight sites around each wound (4-5 mm distance from the wound margins) ( Fig. 9 ).
Wound area measurement and wound closure rate. Photos of the wounds were taken with a digital camera on days 0, 4, 8, 12, and 16. The wound area (mm 2 ) was computed and compared to day 0 using Image J-NIH (USA). The times of complete wound closure were recorded and reported as the wound closure rate 30 .
Wound strength testing. On day 16, all of the rats were euthanized and we removed one, 5 × 50 mm sample from each wound. The samples were mounted in a material testing machine. The deformation rate was estimation of the cell numbers. The physical dissector method was used to determine the numerical density (Nv) of the neutrophils, macrophages, and fibroblasts as follows: Statistical analysis. Data are presented as mean ± standard deviation. We used the t-test for statistical analyses of body weight, one-way analysis of variance (ANOVA), and repeated measurement analysis. The LSD test was used for statistical analysis of body weight. ANOVA and the LSD tests were used for the microbiological examination results, wound area measurement, and wound strength tests. We analyzed the wound closure rate on day 16 for each group with the logistic regression model fit and chi-square tests. A p-value of < 0.05 was considered statistically significant. 
